ONEMEDNET CORPORATION Revenue from Contract with Customer, Excluding Assessed Tax
ONEMEDNET CORPORATION (ONMD) reported Revenue from Contract with Customer, Excluding Assessed Tax of $292.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- ONEMEDNET CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $292.00K, a 88.39% increase year-over-year.
- ONEMEDNET CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $96.00K, a 29.93% decline year-over-year.
- ONEMEDNET CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $891.00K, a 3326.92% increase year-over-year.
- ONEMEDNET CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $177.00K, a 24.65% increase year-over-year.
- ONEMEDNET CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.02M, a 11.45% decline from fiscal 2022.
- ONEMEDNET CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.15M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $292.00K 10-Q · filed 2026-08-14 | $388.00K 10-Q · filed 2026-08-14 | $1.28M derived: sum of 3 quarters · filed 2026-08-14 | $1.46M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $96.00K S-1/A · filed 2026-07-08 | $987.00K derived: sum of 2 quarters · filed 2026-07-08 | $1.16M derived: sum of 3 quarters · filed 2026-07-08 | $1.32M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $891.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $1.07M derived: sum of 2 quarters · filed 2026-07-08 | $1.22M derived: sum of 3 quarters · filed 2026-08-14 | $1.36M S-1/A · filed 2026-07-08 | ||
| 2025-09-30 | $177.00K 10-Q · filed 2025-11-14 | $332.00K derived: sum of 2 quarters · filed 2026-08-14 | $468.00K 10-Q · filed 2025-11-14 | $495.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $155.00K 10-Q · filed 2026-08-14 | $292.00K 10-Q · filed 2026-08-14 | $318.00K derived: sum of 3 quarters · filed 2026-08-14 | $460.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $137.00K S-1/A · filed 2026-07-08 | $163.00K derived: sum of 2 quarters · filed 2026-07-08 | $305.00K derived: sum of 3 quarters · filed 2026-07-08 | $532.00K derived: sum of 4 quarters · filed 2026-07-08 | ||
| 2024-12-31 | $26.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $168.00K derived: sum of 2 quarters · filed 2026-07-08 | $395.00K derived: sum of 3 quarters · filed 2026-07-08 | $643.00K S-1/A · filed 2026-07-08 | ||
| 2024-09-30 | $142.00K 10-Q · filed 2025-11-14 | $369.00K derived: sum of 2 quarters · filed 2025-11-14 | $617.00K 10-Q · filed 2025-11-14 | $957.00K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $227.00K 10-Q · filed 2025-08-13 | $476.00K 10-Q · filed 2025-08-13 | $815.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.14M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $248.00K 10-Q · filed 2025-05-14 | $588.00K derived: sum of 2 quarters · filed 2025-05-14 | $914.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.09M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $666.00K derived: sum of 2 quarters · filed 2025-04-15 | $839.00K derived: sum of 3 quarters · filed 2025-04-15 | $1.02M 10-K · filed 2025-04-15 | $1.02M 10-K · filed 2024-04-09 | |
| 2023-09-30 | $326.00K 10-Q · filed 2024-12-17 | $499.00K derived: sum of 2 quarters · filed 2024-12-17 | $681.00K 10-Q · filed 2024-12-17 | $680.92K 10-Q · filed 2023-11-20 | $963.00K derived: sum of 4 quarters · filed 2024-12-17 | |
| 2023-06-30 | $173.00K 10-Q · filed 2024-12-11 | $356.00K 10-Q · filed 2024-12-11 | $637.00K derived: sum of 3 quarters · filed 2024-12-11 | $1.01M derived: sum of 4 quarters · filed 2024-12-11 | ||
| 2023-03-31 | $200.00K 10-Q · filed 2024-12-05 | $464.00K derived: sum of 2 quarters · filed 2024-12-05 | $839.00K derived: sum of 3 quarters · filed 2024-12-05 | |||
| 2022-12-31 | $264.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $639.00K derived: sum of 2 quarters · filed 2024-11-22 | $1.15M 10-K/A · filed 2024-11-05 | $1.15M 10-K · filed 2024-04-09 | ||
| 2022-09-30 | $375.00K 8-K/A · filed 2024-11-22 | $889.00K 8-K/A · filed 2024-11-22 | $888.97K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |